Renal nerve-mediated erythropoietin release confers cardioprotection during remote ischemic preconditioning

Circulation Journal

Volumn 79, Issue 7, 2015, Pages 1557-1567

  Oba, Toyoharu ^a   Yasukawa, Hideo ^a,b   Nagata, Takanobu ^a   Kyogoku, Sachiko ^a   Minami, Tomoko ^a   Nishihara, Michihide ^a   Ohshima, Hideki ^a   Mawatari, Kazutoshi ^a   Nohara, Shoichiro ^a   Takahashi, Jinya ^a   Sugi, Yusuke ^a   Igata, Sachiyo ^a   Iwamoto, Yoshiko ^a   Kai, Hisashi ^a   Matsuoka, Hidehiro ^a   Takano, Makoto ^a   Aoki, Hiroki ^b   Fukumoto, Yoshihiro ^a,b   Imaizumi, Tsutomu ^c  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Cardioprotection; Erythropoietin; JAK STAT; Remote ischemic preconditioning; Renal nerve

Indexed keywords

BCL2L1 PROTEIN, MOUSE; ERYTHROPOIETIN; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; JANUS KINASE; PROTEIN BCL X;

ANIMAL; BAGG ALBINO MOUSE; HEART INFARCTION PREVENTION; HUMAN; INNERVATION; KIDNEY; MALE; METABOLISM; MOUSE; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PERIPHERAL NERVE; SECRETION (PROCESS); VASCULARIZATION;

ANIMALS; BCL-X PROTEIN; ERYTHROPOIETIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING, MYOCARDIAL; JANUS KINASES; KIDNEY; MALE; MICE; MICE, INBRED BALB C; MYOCARDIAL INFARCTION; PERIPHERAL NERVES;

EID: 84934311881     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1171     Document Type: Article

References (47)

1. Mann DL, Bristow MR. Mechanisms and models in heart failure: The biomechanical model and beyond. Circulation 2005; 111: 2837-2849.
2. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol 1995; 25: 567-573.
3. Chen J, Hsieh AF, Dharmarajan K, Masoudi FA, Krumholz HM. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998–2010. Circulation 2013; 128: 2577-2584.
4. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
5. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87: 893-899.
6. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 1997; 96: 1641-1646.
7. Kloner RA. Clinical application of remote ischemic preconditioning. Circulation 2009; 119: 776-778.
8. Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: An update. Nat Rev Cardiol 2011; 8: 619-629.
9. Wei M, Xin P, Li S, Tao J, Li Y, Li J, et al. Repeated remote ischemic postconditioning protects against adverse left ventricular remodeling and improves survival in a rat model of myocardial infarction. Circ Res 2011; 108: 1220-1225.
10. Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: A single-centre randomised, double-blind, controlled trial. Lancet 2013; 382: 597-604.
11. Davies WR, Brown AJ, Watson W, McCormick LM, West NE, Dutka DP, et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: The CRISP stent trial long-term follow-up. Circ Cardiovasc Interv 2013; 6: 246-251.
12. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: Underlying mechanisms and clinical application. Cardiovasc Res 2008; 79: 377-386.
13. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: Evidence suggesting cross-species protection. Clin Sci (Lond) 2009; 117: 191-200.
14. Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP, Gysembergh A, et al. Rabbit heart can be “preconditioned” via transfer of coronary effluent. Am J Physiol 1999; 277: H2451-H2457.
15. Lim SY, Yellon DM, Hausenloy DJ. The neural and humoral pathways in remote limb ischemic preconditioning. Basic Res Cardiol 2010; 105: 651-655.
16. Redington KL, Disenhouse T, Strantzas SC, Gladstone R, Wei C, Tropak MB, et al. Remote cardioprotection by direct peripheral nerve stimulation and topical capsaicin is mediated by circulating humoral factors. Basic Res Cardiol 2012; 107: 241.
17. Seino Y. Remote ischemic conditioning: From organs/tissues to organs. Circ J 2013; 77: 2883-2885.
18. Igarashi G, Iino K, Watanabe H, Ito H. Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease. Circ J 2013; 77: 3037-3044.
19. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005; 11: 305-311.
20. Riksen NP, Hausenloy DJ, Yellon DM. Erythropoietin: Ready for prime-time cardioprotection. Trends Pharmacol Sci 2008; 29: 258-267.
21. Hirata A, Minamino T, Asanuma H, Fujita M, Wakeno M, Myoishi M, et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 2006; 48: 176-184.
22. Obana M, Maeda M, Takeda K, Hayama A, Mohri T, Yamashita T, et al. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction. Circulation 2010; 121: 684-691.
23. Bolli R, Dawn B, Xuan YT. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med 2003; 13: 72-79.
24. Barry SP, Townsend PA, Latchman DS, Stephanou A. Role of the JAK-STAT pathway in myocardial injury. Trends Mol Med 2007; 13: 82-89.
25. Cai ZP, Parajuli N, Zheng X, Becker L. Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol 2012; 107: 277.
26. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: Short communication. Circ Res 2012; 110: 111-115.
27. Slagsvold KH, Rognmo O, Høydal M, Wisløff U, Wahba A. Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ Res 2014; 114: 851-859.
28. Oba T, Yasukawa H, Hoshijima M, Sasaki KI, Futamata N, Fukui D, et al. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2012; 59: 838-852.
29. Zhang W, Petrovic JM, Callaghan D, Jones A, Cui H, Howlett C, et al. Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures. J Neuroimmunol 2006; 174: 63-73.
30. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 1994; 23: 971-975.
31. Jelkmann W. Regulation of erythropoietin production. J Physiol 2011; 589: 1251-1258.
32. Johns EJ, Kopp UC, DiBona GF. Neural control of renal function. Compr Physiol 2011; 1: 731-767.
33. Eckardt KU, LeHir M, Tan CC, Ratcliffe PJ, Kaissling B, Kurtz A. Renal innervation plays no role in oxygen-dependent control of erythropoietin mRNA levels. Am J Physiol 1992; 263: F925-F930.
34. Fink GD, Fisher JW. Erythropoietin production after renal denervation or beta-adrenergic blockade. Am J Physiol 1976; 230: 508-513.
35. Ditting T, Hilgers KF, Stetter A, Linz P, Schönweiss C, Veelken R. Renal sympathetic nerves modulate erythropoietin plasma levels after transient hemorrhage in rats. Am J Physiol Renal Physiol 2007; 293: F1099-F1106.
36. Gebhard C, Petroktistis F, Zhang H, Kammerer D, Köhle C, Klingel K, et al. Role of renal nerves and salt intake on erythropoietin secretion in rats following carbon monoxide exposure. J Pharmacol Exp Ther 2006; 319: 111-116.
37. Riksen NP, Hausenloy DJ, Yellon DM. Erythropoietin: Ready for prime-time cardioprotection. Trends Pharmacol Sci 2008; 29: 258-267.
38. Namiuchi S, Kagaya Y, Ohta J, Shiba N, Sugi M, Oikawa M, et al. High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol 2005; 45: 1406-1412.
39. Ferrario M, Massa M, Rosti V, Campanelli R, Ferlini M, Marinoni B, et al. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction. Eur Heart J 2007; 28: 1805-1813.
40. Nakamura R, Takahashi A, Yamada T, Miyai N, Irie H, Kinoshita N, et al. Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention. Circ J 2009; 73: 1920-1926.
41. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005; 293: 90-95.
42. Hu J, Yan Y, Zhou Q, Ji M, Niu C, Hou Y, et al. Effects of renal denervation on the development of post-myocardial infarction heart failure and cardiac autonomic nervous system in rats. Int J Cardiol 2014; 172: e414–e416, doi:10.1016/j.ijcard.2013.12.254.
43. Hu J, Ji M, Niu C, Aini A, Zhou Q, Zhang L, et al. Effects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats. PLoS One 2012; 7: e45986, doi:10.1371/journal. pone.0045986.
44. Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, et al.Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels 2002; 16: 51-56.
45. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, MacAllister RJ. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: Role of the autonomic nervous system. J Am Coll Cardiol 2005; 46: 450-456.
46. Liem DA, Verdouw PD, Ploeg H, Kazim S, Duncker DJ. Sites of action of adenosine in interorgan preconditioning of the heart. Am J Physiol Heart Circ Physiol 2002; 283: H29-H37.
47. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 2000; 278: H1571-H1576.